Article info
PDFChronic obstructive pulmonary disease
Superiority of “triple” therapy with salmeterol/fluticasone propionate and tiotropium bromide versus individual components in moderate to severe COPD
- Dr D Singh, Medicines Evaluation Unit, University Hospital of South Manchester, Manchester M33 3TR, UK; dsingh{at}meu.org.uk
Citation
Superiority of “triple” therapy with salmeterol/fluticasone propionate and tiotropium bromide versus individual components in moderate to severe COPD
Publication history
- Received July 12, 2007
- Accepted December 23, 2007
- First published February 1, 2008.
Online issue publication
September 01, 2022
Article Versions
- Previous version (9 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
2008 BMJ Publishing Group Ltd and the British Thoracic Society